<DOC>
	<DOCNO>NCT02824731</DOCNO>
	<brief_summary>This protocol compare toxicity radiotherapy radiochemotherapy apply different radiation modality - proton photon . Patients different kind brain tumour foreseen high-dose radiotherapy include . The hypothesis trial rate chronic toxicity 1 year end radiotherapy 15 % low proton compare photon treatment .</brief_summary>
	<brief_title>Comparison Proton Photon Radiotherapy Brain Tumors ( ProtoChoice-Hirn )</brief_title>
	<detailed_description>Non-randomised 2-arm phase II trial comparison proton versus photon radiotherapy brain tumour use standard dos standard combine chemotherapy protocol . Patients assign treatment group choice availability treatment . Patients stratify 4 group , ( 1 ) supratentorial grad III/ IV tumours without pre-irradiation ; ( 2 ) supratentorial grade I/II tumours without pre-irradiation ; ( 3 ) infratentorial tumour without pre-irradiation ; ( 4 ) patient pre-irradiation &gt; 40 Gy tumour area . Radiotherapy dose 54-60 Gy ( RBE ) apply group 1-3 use normal fractionated schedule . In group 4 , 30 Gy ( RBE ) / 5 Gy ( RBE ) per fraction 36 Gy ( RBE ) 2 Gy ( RBE ) per fraction allow . Primary endpoint chronic toxicity quality life . The hypothesis trial rate chronic toxicity 1 year end radiotherapy 15 % low proton compare photon treatment . Events chronic toxicity toxicity observe later 3 month end radiotherapy score CTC-AE4.0 &gt; grade 2 decrease Quality life &gt; 10 % ( EORTC-QLQ C30 BN20 ) decrease neuropsychological functioning &gt; 10 % ( MoCa test ) . All statistical calculation apply group ( 1 ) , i.e . supratentorial grade II/IV tumours without pre-irradiation , arm close group ( 1 ) close .</detailed_description>
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>primary brain tumor : glioma ( low high grade ) , intracerebral meningioma , pituitary adenoma , craniopharyngioma rare brain tumor brain tumor recurrence without preirradiation brain tumor recurrence preirradiation &gt; 40 Gy overlap region recurrence region indication radiotherapy radiochemotherapy Both proton photon therapy possible medical point view ( standard indication proton standard indication example onetime stereotaxy age &gt; = 18 year general condition ECOG â‰¤ 2 , outpatient basis possible indication high dose ( except group 4 ) radiotherapy radiochemotherapy capacity consent present write informed consent lack capacity consent lack write consent cerebral lymphoma brain metastasis small tumor ( example acoustic neuroma , small recurrence ) proton therapy medical point view alternative stereotactic radiotherapy inability MRI planning ( eg . contraindication perform MRI ) lack compliance patient lack limited possibility reproducible storage ( eg severe restriction mobility patient ) miss limited possibility regular followup visit accordance study protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>brain tumor</keyword>
	<keyword>proton radiotherapy</keyword>
	<keyword>photon radiotherapy</keyword>
</DOC>